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 Background: In thyroid nodules with indeterminate cytology, further clinical assessment aimed at ruling out malignancy is 
often mandatory. Ancillary imaging techniques and genetic mutation analysis can improve the risk stratifica-
tion of such lesions, thereby facilitating the clinician’s decision to undertaken surgery or simple follow-up. The 
aim of this study was to evaluate the diagnostic performance of shear-wave elastography (SW), strain elastog-
raphy (ELX 2/1), conventional ultrasound (US), contrast-enhanced ultrasound (CEUS), and BRAF V600E muta-
tion analysis in the aforementioned lesions.
 Material/Methods: We enrolled 81 patients, each with 1 indeterminate-cytology thyroid nodule. Thyroid function, thyroperoxidase 
antibodies and calcitonin were known in each case. SW, ELX 2/1, US, CEUS, and BRAF mutation analysis were 
subsequently performed, followed by a second FNAB. If the lesion was not downgraded to benign, surgery was 
recommended and histological reports collected.
 Results: There were 28 nodules (34%) that proved benign on the second FNAB; 38 nodules (47%) underwent surgery 
(17 benign, 21 malignant), and 15 nodules (19%) refused surgery. The only techniques related to histological 
outcome were US (AUC=0,766), ELX 2/1 (AUC=0.701), and BRAF analysis (AUC=0.762). ELX 2/1 and SW reports 
were not correlated with each other (P=0.45). A scoring system taking into account all the variables considered 
performed better than the single variables alone (AUC=0.831).
 Conclusions: In indeterminate-cytology thyroid lesions, repeating FNAB can avoid unnecessary surgery. ELX 2/1 seems to 
perform better than SW in distinguishing malignancy; these techniques could, however, be complementary in 
describing such lesions. A multiparametric approach appears the most accurate in predicting nodule histology.
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Background
The clinical management of thyroid nodules with indetermi-
nate cytology is still controversial [1,2]. Despite continuous 
updating of cytological classifications in order to improve the 
risk stratification of these lesions, a significant number of nod-
ules still do not reach a cytological definition [3–8]. In such 
cases, physicians have to adopt a clinical approach that can 
balance the risk of malignancy and the need to avoid useless 
surgery. Several ancillary techniques are now available to sup-
port this choice; molecular tests for genetic mutations have 
shown considerable specificity and positive predictive value 
in detecting malignancies [3,9–11], and the use of combined 
tests has been seen to enhance their negative predictive val-
ue [11]. However, the routine use of complete genetic profil-
ing may not be feasible [9].
Although many imaging techniques can be used to assess 
thyroid nodules, none is yet able to distinguish malignant le-
sions from benign lesions in the event of indeterminate cytol-
ogy. Moreover, the use of nuclear medicine techniques, such 
as 18FDG-PET, adds no further information in such cases [12]. 
Conventional ultrasound (US) has proved helpful in the manage-
ment of these lesions, and several scoring systems with satisfac-
tory accuracy and predictive value are now available [3,6,13–18]. 
While few data are available on the role of contrast-enhanced 
ultrasound (CEUS) in indeterminate-cytology nodules [19], its 
utility in distinguishing benign from malignant thyroid lesions 
and in the evaluation of cervical lymph nodes has already been 
proved [20–22]. Elastosonography is an emerging tool in the field 
of neck imaging and is particularly useful for the evaluation of 
thyroid nodules, especially if combined with conventional ultra-
sound [19,23–25]. Different elastosonographic techniques can 
be used to estimate nodule stiffness [26]; the shear-wave (SW) 
technique allows quantitative assessment but has not proved 
superior to the semi-quantitative techniques (strain index, ELX 
2/1) in identifying malignancies [27]. The aim of the present 
study was to determine the clinical utility and diagnostic perfor-
mance of BRAF gene mutation analysis, conventional US, CEUS, 
SW, and ELX 2/1 in thyroid nodules classified as indeterminate 
on previous fine-needle aspiration biopsy (FNAB).
Material and Methods
Patients
All consecutive patients with at least one thyroid nodule with 
indeterminate cytology (Thy 3a, Thy3f, or Thy4 according to 
the BTA classification) on FNAB performed between March 
2014 and May 2017 in our Institute were enrolled in the study. 
Thyroid function tests, thyroid antibodies and calcitonin were 
recorded in all patients.
At the time of the first FNAB, a US score based on 5 items (so-
lidity, echogenicity, presence of irregular margins, internal vas-
cularization and microcalcifications) was attributed to each 
nodule. All FNAB were performed under sonographic guidance. 
BRAF V600E codon mutation was also investigated. After the 
first FNAB, all patients underwent both strain and shear-wave 
elastosonography and contrast-enhanced ultrasound exami-
nation (CEUS). A second FNAB was performed 1 to 5 months 
after the previous one. Patients whose nodules proved cyto-
logically benign started a follow-up program and dropped out 
from the present study; if the second FNAB was indicative of 
malignancy or yielded another indeterminate result, surgery 
was performed. Histology reports were collected and used as 
outcome for statistical purposes. Written informed consent to 
participate in the in the study was obtained from all patients.
Blood tests
Blood samples were analyzed by means of ultra-sensitive che-
miluminescence immunoassay (Roche Diagnostics, Mannheim, 
Germany) for the evaluation of TSH and fT4 (normal ranges 
0.3–4.2 mU/L for TSH, 15.4–28.3 pmol/L for fT4). The Dia Sorin 
assay (Saluggia, Italy) was used for thyroperoxidase antibod-
ies (TPOAb), and concentrations <100 U/mL were considered 
negative. For serum calcitonin, a chemiluminescence immuno-
assay (Dia Sorin) was used, with 10 ng/L being taken as the 
upper limit of the normal range.
Ultrasound assessment and FNAB
All FNAB were performed at the Endocrine Unit by an endo-
crinologist with over 20 years of experience in thyroid nod-
ule diagnosis and management, who used a 22-gauge needle. 
The same physician validated all the conventional US exam-
inations, which were carried out by means of a conventional 
high-resolution device with a color Doppler module equipped 
with a ML 4-13 linear probe working at 7.5 MHz (MyLab Five, 
Esaote Biomedica, Genoa, Italy).
Elastosonographic and CEUS assessment
Elastosonographic and CEUS examinations were performed 
as previously reported [3] at the Interventional Radiology Unit 
and validated by the same radiologist with more than 5 years 
of experience in elastosonography. Conventional US and USE 
were performed by means of a hand-held GE Logiq E9 US scan-
ner (GE Medical, Milwaukee, IL, USA) equipped with ML 6-15 
linear probe working in the range of 6–15 MHz. In all elasto-
sonography procedures, the USE features of the tissues were 
quantified by means of software pre-installed on the US ma-
chine. The same radiologist performed both strain and shear-
wave USE in the same session. The strain USE was assessed by 
means of a semi-quantitative method, in which the elasticity 
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score was calculated as the ratio between the elasticity of the 
nodule and that of a region of interest (ROI) located in the nor-
mal thyroid parenchyma at the same depth as the nodule [15].
Shear-wave USE yields a quantitative assessment of the elas-
ticity of a nodule by evaluating the speed of propagation of 
the shear-wave in the tissues, and provides a numerical value 
expressed in kilopascals (KPa) or meters per second (m/s). A 
single value was recorded after setting a ROI in the center of 
the nodule and excluding potential confounders, such as cys-
tic or calcific elements.
CEUS images were collected by a MyLab 70 US scanner after 
injection of a bolus of 4.8 mL SonoVue (Bracco, Milan, Italy). 
Time-to-peak (TTP) and Peak-index (PI) were calculated from 
the ratio between the nodule and the selected ROI enhance-
ment by means of the software installed on the US scanner.
Pathology and molecular biology analyses
All cytological and histological evaluations were carried out by 
the same pathologist, who had more than 10 years of experi-
ence in analyzing thyroid cancer. Results were reported accord-
ing to the 2014 BTA classification. Once the adequacy of the 
sample had been checked (>50% of neoplastic cells) and DNA 
extracted, BRAF V600E mutation was investigated by means 
of the direct Sanger sequencing method, in accordance with 
the recommendations of the Italian Association of Medical 
Oncology (AIOM) and the Italian Society of Pathology and 
Cytology (SIAPEC), or real-time polymerase chain reaction (PCR) 
with commercial kits approved for clinical use. The laboratory 
was accredited by Bureau Veritas International Organization 
for Standardization (ISO) 9001: 2008 and the external quali-
ty control for the determination of BRAF and RAS mutations 
was approved by the AIOM in 2012.
Surgery
Surgery was carried out by a team of endocrine surgeons at 
San Martino Hospital, each of whom had more than 10 years 
of experience in thyroid cancer management and performed 
at least 100 thyroidectomies annually for thyroid malignancies.
Statistical analysis
MedCalc Portable Launcher software version 2.2.0.0 was used 
for statistical analyses: correlation between ELX 2/1 and SW 
was evaluated through linear regression analysis, the Mann-
Whitney test was used to compare groups of variables with 
non-parametric distribution, and ROC curves were used to es-
tablish cut-off values, sensitivity and specificity for each di-
agnostic test.
Data collection and subsequent analysis were performed in 
compliance with the Helsinki Declaration and approved by the 
Ethics Committee of the Interdisciplinary Group for Thyroid 
Pathology of Policlinico San Martino.
Results
We enrolled 81 patients (24 males, 57 females) with a medi-
an age of 59.4±15.3 years at the time of the first FNAB; each 
patient had one nodule.
Subclinical hyperthyroidism (TSH <0.5 mU/L) was diagnosed 
in 9 patients. TPOAb exceeded 100 U/mL in 8 patients: out of 
them 2 presented subclinical hypothyroidism (TSH >5.0 mU/L). 
Calcitonin was not elevated (>5 pg/mL) in any patient.
Of these 81 nodules, 28 proved benign (Thy2) on the second 
FNAB. In the remaining 53 cases, cytology was again indeter-
minate in 46 and was non-diagnostic in 7, and they were ad-
vised to surgery; out of these patients, 14 (8 indeterminate, 6 
non-diagnostic) chose to join a follow-up program instead of 
undergoing surgery and 1 patient (Thy 3a at the second FNAB) 
was lost to follow-up. Thus, 38 patients (47%) underwent sur-
gery. Of these, 17 had a benign histological report (nodular 
hyperplasia or follicular adenoma) while 21 had a diagnosis 
of malignancy (16 papillary thyroid cancers, 2 medullary thy-
roid cancers, 1 follicular variant of papillary thyroid cancer, 1 
follicular thyroid cancer, 1 metastasis from lung carcinoma).
Of the 46 lesions resulted as Thy 3a on the first FNAB, 13 un-
derwent surgery; 7 of these proved malignant (54%). Surgery 
was performed in 11 of the 18 Thy 3f nodules, only one of 
which proved malignant (9%); 17 lesions were classified as Thy 
4 on the first FNAB, and all but 3 underwent surgery. Of these 
14 lesions, 13 proved malignant and the remaining 1 was fol-
licular hyperplasia (malignancy 92.8%).
In 7 patients, ELX 2/1 was not feasible owing to the lack of nor-
mal parenchyma in which to set a ROI, the prevalence of the 
liquid component or the position of the nodule; SW was always 
possible. No significant correlation was found between ELX 2/1 
and SW values in the 70 cases in which they were both available 
(P=0.45) (Figure 1). A significant difference was seen between 
the ELX 2/1 values recorded in benign and malignant nodules 
(P=0.05; Figure 2), but not between the SW values (P=0.20; 
Figure 3). The difference in US scores between benign and ma-
lignant nodules was much more significant (P=0.005; Figure 4).
ROC curve analysis of the specificity and sensitivity of each tool 
in distinguishing benign from malignant nodules yielded a cut-
off of 2 for the US score (sensitivity 73.68%, specificity 75%, 
P=0.002) and of 1.73 for ELX 2/1 (sensitivity 50%, specificity 
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86.7%, P=0.02), while SW showed no statistical significance 
(P=0.09, cut-off 20 KPa). With regard to CEUS, TTP and PI did 
not prove useful in distinguishing benign from malignant le-
sions (P=0.97 and P=0.72, respectively).
A mutation of the BRAF V600E exon was found in 11 nodules 
(13.5%). As expected, this test displayed perfect specificity 
but low sensitivity in detecting malignancies (sensitivity 40%, 
specificity 100%, P=0.0004). On the other hand, calcitonin was 
very specific in detecting medullary thyroid carcinomas, with 
values above 45 ng/L in the only 2 cases found.
In order to assess the relative weight of each tool, odds ra-
tios were calculated: SW and BRAF had the highest OR (30.7, 
P=0.020 and 38.33, P=0.015, respectively), the US score and ELX 
2/1 showed similar values (8.12, P=0.005 and 7.72, P=0.018), 
while CEUS had the lowest ones (1.62, P=0.050 and 1.9, P=0.329 
for TTP and PI, respectively). In order to improve the accuracy 
of the examination, we created a scoring system that assigned 
one point to each of the following items: ELX 2/1 >1.73, US 
score>2, BRAF V600E mutated. This score displayed 100% spec-
ificity and 68.4% sensitivity for values >1 (P<0.0001, Figure 5). 
Lastly, a scoring system that included all the variables we con-
sidered (US score >2, ELX 2/1 >1.73, SW >20 KPa, TTP ³1.10 s, 
PI £0.97 s and BRAF V 600E mutation) was applied to the 35 
cases in which all these variables were available. This score 
showed good sensitivity in detecting malignant lesions (crite-
rion >2, sensitivity 89.5%, specificity 75%, P<0.0001; Figure 5).
Discussion
FNAB is the gold standard examination for characterizing thy-
roid nodules after a primary ultrasonographic assessment [28]. 
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Figure 1.  Linear regression graph showing ELX 2/1 and SW 
values. No significant correlation was found between 
the 2 variables (n=81, P=0.45).
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Figure 2.  Comparison between ELX 2/1 values in benign and 
malignant nodules (Mann-Whitney test). The former 
proved to be significantly softer than the latter 
(P=0.05).
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Figure 3.  Comparison between SW values in benign and 
malignant nodules (Mann-Whitney test) expressed in 
kilopascals (KPa). No significant difference was noted 
between the 2 groups (P=0.20).
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Figure 4.  Comparison between US scores in benign and 
malignant nodules (Mann-Whitney test). Malignant 
lesions had significantly higher values than benign 
lesions (P=0.005).
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In the event of an indeterminate cytology result, the repetition 
of FNAB can rule out malignancy in 30–60% of cases [28,29] and 
could therefore reduce unnecessary thyroidectomies [31]. One 
study reported an increased prevalence of malignancy when 
FNAB was repeated [30]; however, this finding may have been 
due to the fact that, in that study, the second FNAB was per-
formed in those nodules in which clinical and ultrasonographic 
risk was higher. Indeed, similar findings did not emerge from 
previous studies [28–30]. If the second FNAB yields an indeter-
minate or non-diagnostic result, a follow-up program should 
always be considered; this will also depend on the age and 
clinical conditions of the single patient [29]. In patients with 
no absolute contraindication to surgery, however, further as-
sessment is mandatory.
We particularly focused on the use of elastography, as sever-
al studies have found that low elasticity of the lesion is re-
lated with a higher incidence of malignancy [32–34], though 
it is also related with other histological features, such as the 
presence of fibrosis and the expression of galectin-3 and fi-
bronectin-1 [33]. Although elastography can be performed in 
various ways and by means of various techniques [25], there 
is no consensus as to which approach is most able to rule out 
malignancy. In many cases, indeed, the semi-quantitative and 
operator-dependent real-time elastosonography (ELX 2/1) tech-
nique has shown a better performance than the more recent 
shear-wave technique [24, 26, 35]. Our data confirm this no-
tion, since the ELX 2/1 score was the only parameter that cor-
related significantly with histological outcomes. We also noted 
that the results of ELX 2/1 and SW were not related to each 
other. This may be due to the fact they are based on 2 com-
pletely different physical parameters – i.e. the dimensional 
change in diameters under external pressure in the case of 
ELX 2/1, versus the characteristics of shear-wave propaga-
tion in the case of SW. On the other hand, ELX 2/1 is not al-
ways feasible, owing to the lack of normal thyroid tissue with 
which to compare the nodule, or in those situations in which 
physical compression cannot be applied.
In some cases, an approach that combines different ancillary 
techniques has proved to offer greater diagnostic accuracy 
than a single technique alone [18,36–39]. As reported in previ-
ous studies [15–17,40], our data confirmed the role of conven-
tional ultrasound as the basis for the assessment, owing to its 
advantages in terms of cost and time. However, the need for 
a scoring system that performs better than the separate eval-
uation of single items is increasingly evident. Many different 
systems have been created in order to meet this need [16,17]; 
hypo-echogenicity, irregular margins, and the presence of mi-
crocalcifications are acknowledged to be risk factors for ma-
lignancy, while the role of intra-nodular vascularization is still 
debated [3,22,27,41].
In this regard, we found that, when the only tools we found 
to be significantly related to malignancy (US score, ELX 2/1 
and BRAF mutation) were considered together, specifici-
ty was improved, but sensitivity was lower than that of the 
US score alone. However, on combining all the data we had, 
a high level of sensitivity was reached, while specificity re-
mained acceptable.
The present study was certainly limited by the relatively small 
number of patients involved and, in particular, by the lack of 
histological diagnoses in many cases; this was due to the small 
Figure 5.  ROC curves showing sensitivity and specificity of combined scores. A three-item score (A) (ELX 2/1 >1.73, US score>2, BRAF 
V600E mutated) had 100% specificity and 68.4% sensitivity for values >1 (P<0.001). The score which took into account all 
the available items (B) (US score >2, ELX 2/1 >1.73, SW >20 KPa, TTP ³1.10 s, PI £0.97 s and BRAF V 600E mutation) showed 
89.5% sensitivity and 75% specificity for values >2 (P<0.0001).
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number of FNAB that proved indeterminate. Nodules classi-
fied as benign on the second biopsy, however, were assigned 
to a follow-up program, in order to verify the absence of evo-
lution of the lesion over time. Cut-off values obtained through 
ROC curve analysis could be influenced by the sample size and, 
sometimes, by the operator who performs the examination. For 
this reason, it is important for every center which carries out 
this kind of diagnostic investigation to have its own reference 
values, given the absence of universally standardized ones.
At last, it is important to specify that since a great inter-ob-
server variability has widely been described both for US [42] 
and for cytological [43] evaluation of thyroid nodules, the pres-
ence of a single operator who analyzed all the cases in our 
study could be a limitation for the application of such data to 
the routine clinical practice.
Conclusions
The management of thyroid nodules with indeterminate cy-
tology remains an area of diagnostic uncertainty. In about half 
of these cases, a second FNAB can rule out surgery. Many an-
cillary tools for the further assessment of these patients are 
available; each technique has its own peculiarity and can pro-
vide the clinician with particular information. A good knowl-
edge of each technique allows physicians to maximize diag-
nostic performance and to combine the various techniques in 
order to obtain better sensitivity or specificity, according to 
their needs. ELX 2/1 seems to perform better than SW in dis-
tinguishing malignancy. Moreover, these 2 techniques do not 
appear to be related to each other nor interchangeable; they 
may instead be complementary in the context of a multipa-
rametric assessment of lesions with indeterminate cytology.
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